TKPHF
Price
$27.05
Change
-$2.45 (-8.31%)
Updated
Jul 25 closing price
Capitalization
47.94B
ZTS
Price
$152.12
Change
-$0.70 (-0.46%)
Updated
Jul 25 closing price
Capitalization
77.48B
10 days until earnings call
Interact to see
Advertisement

TKPHF vs ZTS

Header iconTKPHF vs ZTS Comparison
Open Charts TKPHF vs ZTSBanner chart's image
Takeda Pharmaceutical
Price$27.05
Change-$2.45 (-8.31%)
Volume$250.17K
Capitalization47.94B
ZOETIS
Price$152.12
Change-$0.70 (-0.46%)
Volume$3.33M
Capitalization77.48B
TKPHF vs ZTS Comparison Chart in %
Loading...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TKPHF vs. ZTS commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKPHF is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (TKPHF: $27.05 vs. ZTS: $152.12)
Brand notoriety: TKPHF: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TKPHF: 556% vs. ZTS: 110%
Market capitalization -- TKPHF: $47.94B vs. ZTS: $77.48B
TKPHF [@Pharmaceuticals: Other] is valued at $47.94B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKPHF’s FA Score shows that 2 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • TKPHF’s FA Score: 2 green, 3 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKPHF’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • TKPHF’s TA Score: 5 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both TKPHF and ZTS are a good buy in the short-term.

Price Growth

TKPHF (@Pharmaceuticals: Other) experienced а +1.31% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

TKPHF is expected to report earnings on May 08, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than TKPHF($47.9B). ZTS has higher P/E ratio than TKPHF: ZTS (32.94) vs TKPHF (22.47). TKPHF YTD gains are higher at: 1.121 vs. ZTS (-5.722). TKPHF has higher annual earnings (EBITDA): 1.15T vs. ZTS (3.67B). TKPHF has more cash in the bank: 369B vs. ZTS (2.04B). ZTS has less debt than TKPHF: ZTS (6.76B) vs TKPHF (4.75T). TKPHF has higher revenues than ZTS: TKPHF (4.11T) vs ZTS (8.54B).
TKPHFZTSTKPHF / ZTS
Capitalization47.9B77.5B62%
EBITDA1.15T3.67B31,451%
Gain YTD1.121-5.722-20%
P/E Ratio22.4732.9468%
Revenue4.11T8.54B48,151%
Total Cash369B2.04B18,097%
Total Debt4.75T6.76B70,274%
FUNDAMENTALS RATINGS
TKPHF vs ZTS: Fundamental Ratings
TKPHF
ZTS
OUTLOOK RATING
1..100
8858
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
8419
PRICE GROWTH RATING
1..100
5462
P/E GROWTH RATING
1..100
2280
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is somewhat better than the same rating for ZTS (61) in the Pharmaceuticals Generic industry. This means that TKPHF’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (79) in the Pharmaceuticals Generic industry is in the same range as TKPHF (100) in the null industry. This means that ZTS’s stock grew similarly to TKPHF’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TKPHF (84) in the null industry. This means that ZTS’s stock grew somewhat faster than TKPHF’s over the last 12 months.

TKPHF's Price Growth Rating (54) in the null industry is in the same range as ZTS (62) in the Pharmaceuticals Generic industry. This means that TKPHF’s stock grew similarly to ZTS’s over the last 12 months.

TKPHF's P/E Growth Rating (22) in the null industry is somewhat better than the same rating for ZTS (80) in the Pharmaceuticals Generic industry. This means that TKPHF’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TKPHFZTS
RSI
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
54%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 18 days ago
45%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bearish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRL176.93-0.17
-0.10%
Charles River Laboratories International
OKYO2.75-0.01
-0.36%
OKYO Pharma Limited
PLOW29.25-0.17
-0.58%
Douglas Dynamics
AMST3.18-0.06
-1.85%
Amesite
HBM9.87-0.25
-2.47%
Hudbay Minerals

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.46%
ELAN - ZTS
48%
Loosely correlated
+1.57%
VTRS - ZTS
44%
Loosely correlated
+0.64%
PAHC - ZTS
41%
Loosely correlated
-0.88%
AMRX - ZTS
39%
Loosely correlated
+0.75%
PBH - ZTS
35%
Loosely correlated
+0.79%
More